Primary tabs

Export products to Excel

Displaying 136 - 150 of 213
Product Alternative Name Development Status Target Mode Active Pharmaceutical Ingredient (API) Delivery Type Duration Type Project Stage Partner Updated date
Oleanolic Acid Inactive Male Non-hormonal Oleanolic acid Oral TBD Pre-clinical South African Medical Research Council, University of Western Cape 05/30/2018
Omega Cu 320 Active Development Female Non-hormonal copper Intrauterine Long-acting Contrel Research, Belgium 05/30/2018
Omega LNG IUS Active Development Female Hormonal levonorgestrel Intrauterine Long-acting Regulatory Contrel Research, Belgium 05/30/2018
Onapristone ZK 98.299, ZK 98 299 Inactive Female Hormonal Onapristone TBD TBD Pre-clinical Schering AG 07/22/2016
Oral Testosterone Male Hormonal testosterone Oral Short-acting Phase I University of Washington, GlaxoSmithKline, NICHD 05/30/2018
Origami Female Condom Inactive Female Non-hormonal Barrier Pericoital Regulatory NIAID, NICHD, Origami Healthcare Products, Inc., Strata Various Product Design 05/30/2018
OvaPrene Active Development Female Non-hormonal Barrier, Vaginal Ring Short-acting Phase II Dare BioScience Inc. 05/30/2018
OvoControl Inactive Female Non-hormonal nicarbazin Oral Short-acting Target ID/Validation Innolytics LLC 05/30/2018
O’Lavie Female Condom Woman's Condom (WC) SRA/WHO PQ Approved Female Non-hormonal Barrier Pericoital Marketed Shanghai Dahua Medical Apparatus Co., Ltd, PATH 07/22/2016
PC6 Inhibitor Proprotein convertase 6 (PC6) inhibitor Female, Male Non-hormonal TBD TBD Target ID/Validation CONRAD, Prince Henry's Institute of Medical Research, Australia 05/30/2018
PCL Microspheres Encapsulating LNG and EE Female Hormonal levonorgestrel, ethinyl estradiol Injectable Pre-clinical Vel's College of Pharmacy 05/30/2018
PDE 3, 5, 9 inhibitors Phosphodiesterase (PDE) 3, 5, 9 inhibitors, PDE3A Active Development Female Non-hormonal TBD TBD Target ID/Validation Oregon Health & Science University, University of Minnesota 05/30/2018
Peptide LL-37 Active Development Female Non-hormonal LL-37 Vaginal Gel, Vaginal Ring Long-acting, Pericoital Lead Optimization Ottawa Hospital Research Institute (OHRI) 05/30/2018
Pericoital Oral LNG Active Development Female Hormonal levonorgestrel Oral Pericoital Phase III HRA Pharma, Gynuity Health Projects, PATH 05/30/2018
Pericoital UPA + Meloxicam Active Development Female Hormonal ulipristal acetate, meloxicam Oral Phase I Stanford University 12/04/2017
Export to Excel